Cytokine is required for normal fertility in males and females.
Promotes actin cytoskeleton reorganization, regulates cell adhesion and cell migration. Plays a role in lipoprotein clearance.
Inflammation: Colony-stimulating factor 1 (CSF1) and interleukin-34 (IL34) act as ligands to control macrophage differentiation via the CSF1 receptor (Lin W et al 2019). Animal experiments have established their role in macrophage differentiation by neutralizing CSF1 and/or IL34, particularly in stationary microglia, Langerhans cells, and renal macrophages. IL34 and CSF1 play a non-redundant role in macrophage differentiation. Thus, therapeutic intervention targeting IL34 and/or CSF1 may be an effective treatment for macrophage-related immunopathies (Lin W et al. 2019). IL-34 and colony-stimulating factor 1 (CSF1) are two alternative ligands for the CSF1 receptor that play non-redundant roles in the development, survival, and function of tissue macrophages and Langerhans cells (LCs) (Wang Y et al. 2016).
However, during UV-induced skin damage, the regeneration of LCs depends on neutrophil granulocytes entering the skin, which produced large amounts of CSF1. (Wang Y et al 2016).
Oncology: The association between macrophage colony-stimulating factor-1 receptor (CSF-1R) expression and prognosis of cancer patients has been investigated in several studies (Mo H et al. 2021). Pooled analysis showed that overexpression of CSF-1R was significantly associated with worse PFS and OS. Overexpression of CSF-1R thus appears to be a predictor of worse prognosis in patients with various malignancies, particularly hematologic malignancies, suggesting that it may be a potential biomarker for predicting cancer survival and a potential molecular target in the treatment of malignancies (Mo H et al. 2021).